NCT00813397已完成不适用
Manageability and Safety Assessment of the SepraSpray Anti-adhesion Barrier in Abdominal Coelioscopic Surgery
Genzyme, a Sanofi Company30 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2008年9月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 210
- 试验地点
- 30
- 主要终点
- Morbidity
研究概览
简要总结
This study will examine the performance of SeprasSpray in patients undergoing abdominal surgery (laparoscopic).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 years old and over that require laparoscopic abdominal surgery
排除标准
- •Patients who are pregnant or have an ongoing infectious complications from a previous surgery
研究组 & 干预措施
Sepraspray
Experimental
Receive Sepraspray
干预措施: Sepraspray (Device)
Control
No Intervention
No Treatment, No Placebo
结局指标
主要结局
Morbidity
时间窗: 30 days
次要结局
未报告次要终点
研究者
研究点 (30)
Loading locations...
相似试验
终止
不适用
Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical AdhesionsAbdominal AdhesionsNCT00665730Genzyme, a Sanofi Company5
终止
不适用
Evaluation of the Safety of Sepraspray in Open Abdominal SurgeryAdhesion Prevention (Abdominal)NCT00778479Genzyme, a Sanofi Company155
Unknown
3 期
SUPRACOR for Myopia and Myopic AstigmatismMyopic AstigmatismMyopiaPresbyopiaNCT01404884Technolas Perfect Vision GmbH60
Unknown
2 期
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric CancerStomach NeoplasmsNCT02845986Fujian Medical University251
已完成
不适用
Study for perioperative management and the safetyAll patients undergone any surgeryJPRN-UMIN000016923Masanori Yamauchi10,000